
    
      Approximately 180 subjects will be enrolled in one of three dose arms ( 4ml, Saline Placebo
      and 4ml 2x). The estimated enrollment period is 6 months. Each subject will receive 1
      injection and be evaluated for efficacy and safety during a 6 month observation period. The
      study is expected to be completed within 12 months, inclusive of enrollment and follow-up for
      all subjects.
    
  